DIGITAL QUANTIFICATION OF Mirna IN BLOOD USING INTEGRATED COMPREHENSIVE DROPLET DIGITAL DETECTION (IC3D) SYSTEM
Dong Ku Kang,Kaixiang Zhang,M. Monsur Ali,Linan Liu,Louai Labanieh,Min Lü,Hamidreza Riazifar,Truong Thao Nguyen,Jason A. Zell,Michelle A. Digman,Enrico Gratton,Jinghong Li,Weian Zhao
2015-01-01
Abstract:Quantification of miRNAs in blood can be potentially used for early disease detection, surveillance monitoring and drug response evaluation. However, quantitative and robust measurement of miRNAs in blood is still a major challenge in large part due to their low concentration and complicated sample preparation processes typically required in conventional assays. Here, we present the ‘Integrated Comprehensive Droplet Digital Detection’ (IC 3D) system where the plasma sample containing target miRNAs is encapsulated into microdroplets, enzymatically amplified and digitally counted using a novel, high-throughput 3D particle counter. Using Let-7a as a target, we demonstrate that IC 3D can specifically quantify target miRNA directly from blood plasma at extremely low concentrations ranging from 10s to 10,000 copies/mL in ≤ 3 hours without the need for sample processing such as RNA extraction. Using this new tool, we demonstrate that target miRNA content in colon cancer patient blood is significantly higher than that in healthy donor samples. KEYWORDS: Droplet-based microfluidic, IC3D, miRNA detection, Lab On A Chip, Cancer INTRODUCTION MicroRNAs (miRNAs) are a class of short (approximately 18-23 nucleotides (nt)), single-stranded, noncoding endogenous RNAs which play important roles in regulating gene expression via target mRNA degradation or translational repression.[1] When cells undergo apoptosis or necrosis in the body, significant amounts of miRNA can be shed into the blood stream. It has been demonstrated that circulating miRNA expression levels are correlated to the disease states of various diseases including cancer, neurodegenerative disorders and cardiovascular diseases. Therefore, miRNAs can potentially be used as convenient blood test markers for early disease detection, surveillance monitoring and drug response evaluation. However, accurate quantification of circulating miRNA biomarkers in blood that often exist at low concentrations for early-stage, metastatic or recurrent diseases is still a major challenge. Due to the low abundance of target miRNAs, large input clinical sample volumes (100s μLs to mLs) are typically required, which few conventional detection systems can directly handle without sample preparation and volume reduction. Therefore, there is a great need for a new technology that is more sensitive, robust and can directly detect miRNAs in a large volume of patient blood samples without the need for complex sample preparation. THEORY Recently, we have developed a platform technology termed ‘Integrated Comprehensive Droplet Digital Detection (IC 3D)’ that integrates real-time fluorescent sensors, droplet microencapsulation and a 200 978-0-9798064-8-3/μTAS 2015/$20©15CBMS-0001 19 International Conference on Miniaturized Systems for Chemistry and Life Sciences October 25-29, 2015, Gyeongju, KOREA high-throughput 3D particle counter for rapid digital analysis.[2] In our previous work, we demonstrated that the IC 3D can selectively detect bacteria directly from diluted blood at single-cell sensitivity using microencapsulated DNAzyme sensors. Here, we demonstrate that the IC 3D can be used to accurately quantify target miRNAs directly from blood plasma because our rationale is that the confinement of samples in picoliter droplets can significantly increase the effective miRNA concentration and minimize the number of background molecules (interference) from plasma. Therefore, microencapsulation permits single-molecule sensitivity and digital detection (i.e., each droplet has 0 or 1 target miRNA). EXPERIMENTAL Specifically, the IC 3D system combines microencapsulation for enabling single-molecule digital quantification; isothermal exponential amplification (EXPAR) for specific miRNA detection; and a 3D particle counter for rapid, highthroughput droplet counting (Scheme 1). Briefly, the plasma sample and sensing elements are injected and mixed in a microfluidic device and then immediately encapsulated into hundreds of millions of picolitersized droplets. Microfluidic chip design and operating mechanism are shown in Figure 2a and plasma samples (100%) were encapsulated with EXPAR reagents to form 30 μm diameter droplets. Generated droplets were then collected at 4°C to avoid non-specific EXPAR and EXPAR reaction were perform at 55°C. Fluorescent droplets were then analyzed by using 3D particle counting system for absolute quantification of target miRNA. RESULTS AND DISCUSSION We first validated EXPAR for rapid and real-time miRNA detection in bulk. EXPAR is a homogenous and ultrasensitive isothermal amplification method which has been used for DNA and miRNA detection (Figure 1a). EXPAR can detect 1pM or higher concentrations of Let-7a in plasma but cannot distinguish concentrations below 100fM (Figure 1b). However, EXPAR can specifically distinguish Let-7a from Let-7b and Let-7c in plasma, which only differ by one or two nucleotides (Figure 1c). The EXPAR reagents and plasma are merged within the microfluidic channel and encapsulated into uniform droplets (30 μm in diameter) using a flow-focusing structure (Bottom right panel in Figure 2a). We observed that after a 50 min EXPAR reaction the number of fluorescent droplets that contain single Let-7a molecules increases closely to the predicted number while Let-7b and blank samples have no fluorescent droplets, although non-specific signals begin to arise after 60 min (Figure 2b). Using this system, we have demonstrated that fluorescent droplets that contain single target miRNA, can be detected at single-droplet sensitivity. (Figure (3a,b and c) We next demonstrate that IC 3D can provide digital quantification of target Let-7a at a broad Scheme 1. Schematic diagram of IC 3D technology for miRNA detection. Microencapsulation (step 1), Isother-‐ mal exponential amplification (step 2), High-‐throughput digital droplets are detected (step 3) and data analysis